{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:57:58Z","timestamp":1791331078354,"version":"4.3.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/srao.2001.26030","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"316-327","source":"Crossref","is-referenced-by-count":47,"title":["ATM as a target for novel radiosensitizers"],"prefix":"10.1053","volume":"11","author":[{"given":"Jann N.","family":"Sarkaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Eshleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/srao.2001.26030_bib1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/7.10.1555","article-title":"ATM-from gene to function","volume":"7","author":"Rotman","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1053\/srao.2001.26030_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.immunol.15.1.177","article-title":"The genetic defect in ataxia-telangiectasia","volume":"15","author":"Lavin","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/srao.2001.26030_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1542\/peds.102.1.98","article-title":"Consequences of the delayed diagnosis of ataxia-telangiectasia","volume":"102","author":"Cabana","year":"1998","journal-title":"Pediatrics"},{"key":"10.1053\/srao.2001.26030_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0022-3476(68)80127-1","article-title":"Allergy: Status and perspective","volume":"73","author":"Peterson","year":"1968","journal-title":"J Pediatr"},{"key":"10.1053\/srao.2001.26030_bib5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1172\/JCI105881","article-title":"Immunoglobulin metabolism in ataxia telangiectasia","volume":"47","author":"Strober","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1053\/srao.2001.26030_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#","article-title":"Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients","volume":"92","author":"Li","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1053\/srao.2001.26030_bib7","first-page":"347","volume":"Vol 16","author":"Sedwick","year":"1991"},{"key":"10.1053\/srao.2001.26030_bib8","first-page":"89","article-title":"Mortality and cancer incidence in 263 patients with ataxia-telangiectasia","volume":"77","author":"Morrell","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/srao.2001.26030_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-4608(90)90003-S","article-title":"Cancer in ataxia-telangiectasia patients","volume":"46","author":"Hecht","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/srao.2001.26030_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B","article-title":"Treatment of lymphoid malignancies in patients with ataxia-telangiectasia","volume":"31","author":"Sandoval","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1053\/srao.2001.26030_bib11","first-page":"8","article-title":"Cancer susceptibility in ataxia-telangiectasia","volume":"6","author":"Peterson","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/srao.2001.26030_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ng0997-96","article-title":"Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia","volume":"17","author":"Vorechovsky","year":"1997","journal-title":"Nat Genet"},{"key":"10.1053\/srao.2001.26030_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.onc.1201603","article-title":"Atm is usually rearranged in T-cell prolymphocytic leukaemia","volume":"16","author":"Yuille","year":"1998","journal-title":"Oncogene"},{"key":"10.1053\/srao.2001.26030_bib14","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1182\/blood.V91.10.3920.3920_3920_3926","article-title":"Inactivation of the ATM gene in T-cell prolymphocytic leukemias","volume":"91","author":"Stoppalyonnet","year":"1998","journal-title":"Blood"},{"key":"10.1053\/srao.2001.26030_bib15","first-page":"4552","article-title":"Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia","volume":"58","author":"Starostik","year":"1998","journal-title":"Cancer Research"},{"key":"10.1053\/srao.2001.26030_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(98)10117-4","article-title":"Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia","volume":"353","author":"Stankovic","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/srao.2001.26030_bib17","first-page":"557","article-title":"Radiation reaction in ataxia telangiectasia","volume":"116","author":"Morgan","year":"1968","journal-title":"Am J Dis Children"},{"key":"10.1053\/srao.2001.26030_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","article-title":"Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis","volume":"114","author":"Gotoff","year":"1967","journal-title":"Am J Dis Children"},{"key":"10.1053\/srao.2001.26030_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-3476(70)80011-7","article-title":"Ataxia telangiectasia with granulocytopenia","volume":"77","author":"Feigin","year":"1970","journal-title":"J Pediatr"},{"key":"10.1053\/srao.2001.26030_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/1097-0142(19820901)50:5<877::AID-CNCR2820500513>3.0.CO;2-U","article-title":"The effects of radiation therapy for Hodgkin's disease in a child with ataxia telangiectasia: A clinical, biological and pathologic study","volume":"50","author":"Pritchard","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/srao.2001.26030_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1357-2725(99)00028-X","article-title":"ATM: The product of the gene mutated in ataxia-telangiectasia","volume":"31","author":"Lavin","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/srao.2001.26030_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1034\/j.1399-0004.1999.550501.x","article-title":"Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene","volume":"55","author":"Meyn","year":"1999","journal-title":"Clin Genet"},{"key":"10.1053\/srao.2001.26030_bib23","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/hmg\/4.11.2025","article-title":"The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species","volume":"4","author":"Savitsky","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1053\/srao.2001.26030_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O","article-title":"Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia","volume":"10","author":"Concannon","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1053\/srao.2001.26030_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<69::AID-HUMU11>3.0.CO;2-X","article-title":"Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in Israel","volume":"11","author":"Gilad","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1053\/srao.2001.26030_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/301706","article-title":"ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer","volume":"62","author":"Stankovic","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1053\/srao.2001.26030_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/301673","article-title":"Ataxia-telangiectasia: Identification and detection of founder effect mutations in the ATM gene in ethnic populations","volume":"62","author":"Telatar","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1053\/srao.2001.26030_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/5.4.433","article-title":"Predominance of null mutations in ataxia-telangiectasia","volume":"5","author":"Gilad","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1053\/srao.2001.26030_bib29","first-page":"2707","article-title":"Analysis of the ATM protein in wild-type and ataxia telangiectasia cells","volume":"13","author":"Lakin","year":"1996","journal-title":"Oncogene"},{"key":"10.1053\/srao.2001.26030_bib30","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1073\/pnas.94.15.8021","article-title":"Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/srao.2001.26030_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.onc.1201319","article-title":"Recombinant ATM protein complements the cellular A-T phenotype","volume":"15","author":"Ziv","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/srao.2001.26030_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.270.5233.50","article-title":"PIK-related kinases: DNA repair, recombination and cell cycle checkpoints","volume":"270","author":"Keith","year":"1995","journal-title":"Science"},{"key":"10.1053\/srao.2001.26030_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0959-437X(97)80125-6","article-title":"Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family","volume":"7","author":"Hoekstra","year":"1997","journal-title":"Curr Opin Genet Dev"},{"key":"10.1053\/srao.2001.26030_bib34","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"10.1053\/srao.2001.26030_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1074-7613(00)80618-4","article-title":"Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity","volume":"9","author":"Taccioli","year":"1998","journal-title":"Immunity"},{"key":"10.1053\/srao.2001.26030_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: Putting checkpoints in perspective","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature"},{"key":"10.1053\/srao.2001.26030_bib37","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/sj.onc.1203593","article-title":"An N-terminal p14(ARF) peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo","volume":"19","author":"Midgley","year":"2000","journal-title":"Oncogene"},{"key":"10.1053\/srao.2001.26030_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein Mdm2 is a ubiquitin ligase E3 for tumor suppressor p53","volume":"420","author":"Honda","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1053\/srao.2001.26030_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"10.1053\/srao.2001.26030_bib40","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1128\/MCB.18.10.5690","article-title":"Regulation of Mdm2-directed degradation by the C terminus of p53","volume":"18","author":"Kubbutat","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1053\/srao.2001.26030_bib41","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.1073\/pnas.96.26.14973","article-title":"Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage","volume":"96","author":"Khosravi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/srao.2001.26030_bib42","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","article-title":"Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage","volume":"96","author":"Chehab","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/srao.2001.26030_bib43","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1101\/gad.11.24.3471","article-title":"DNA damage induces phosphorylation of the amino terminus of p53","volume":"11","author":"Siliciano","year":"1997","journal-title":"Genes Dev"},{"key":"10.1053\/srao.2001.26030_bib44","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1126\/science.282.5395.1893","article-title":"Linkage of ATM to the cell cycle regulation by the Chk2 protein kinase","volume":"282","author":"Matsuoka","year":"1998","journal-title":"Science"},{"key":"10.1053\/srao.2001.26030_bib45","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1073\/pnas.96.7.3745","article-title":"A human Cdsl-related kinase that functions downstream of ATM protein in the cellular response to DNA damage","volume":"96","author":"Brown","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/srao.2001.26030_bib46","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/sj.onc.1202925","article-title":"Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway","volume":"18","author":"Chaturvedi","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/srao.2001.26030_bib47","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1101\/gad.14.12.1448","article-title":"Chk1 is an cssential kinase that is regulated by ATR and required for the G(2)\/M DNA damage checkpoint","volume":"14","author":"Liu","year":"2000","journal-title":"Genes Dev"},{"key":"10.1053\/srao.2001.26030_bib48","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.277.5331.1497","article-title":"Conservation of the Chkl checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25","volume":"277","author":"Sanchez","year":"1997","journal-title":"Science"},{"key":"10.1053\/srao.2001.26030_bib49","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.277.5331.1501","article-title":"Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216","volume":"277","author":"Peng","year":"1997","journal-title":"Science"},{"key":"10.1053\/srao.2001.26030_bib50","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2307\/3578780","article-title":"Ionizing radiation and cell cycle progression in ataxia telangiectasia","volume":"138","author":"Beamish","year":"1994","journal-title":"Radiat Res"},{"key":"10.1053\/srao.2001.26030_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/emboj\/17.1.159","article-title":"Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints","volume":"17","author":"Cliby","year":"1998","journal-title":"EMBO J"},{"key":"10.1053\/srao.2001.26030_bib52","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1073\/pnas.77.12.7315","article-title":"Radiosensitivity in ataxia-telangiectasia: A new explanation","volume":"77","author":"Painter","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/srao.2001.26030_bib53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35007091","article-title":"ATM phosphorylates p95\/nbs1 in an S-phase checkpoint pathway","volume":"404","author":"Lim","year":"2000","journal-title":"Nature"},{"key":"10.1053\/srao.2001.26030_bib54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0959-437X(00)00069-1","article-title":"DNA double strand break repair in mammalian cells","volume":"10","author":"Karran","year":"2000","journal-title":"Curr Opin Genet Dev"},{"key":"10.1053\/srao.2001.26030_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bjc.1992.226","article-title":"Host cell reactivation of gamma-irradiated adenovirus 5 in human cell lines of varying radiosensitivity","volume":"66","author":"Eady","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1053\/srao.2001.26030_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0027-5107(88)90240-0","article-title":"Examination of vectors with two dominant, selectable genes for DNA repair and mutation studies in mammalian cells","volume":"199","author":"Debenham","year":"1988","journal-title":"Mutat Res"},{"key":"10.1053\/srao.2001.26030_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(00)81175-7","article-title":"The Hmre11\/Hrad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response","volume":"93","author":"Carney","year":"1998","journal-title":"Cell"},{"key":"10.1053\/srao.2001.26030_bib58","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0002-9440(10)65716-1","article-title":"Pathological and physiological double-strand breaks: Roles in cancer, aging, and the immune system","volume":"153","author":"Lieber","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/srao.2001.26030_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0092-8674(00)81626-8","article-title":"The many interfaces of Mre11","volume":"95","author":"Haber","year":"1998","journal-title":"Cell"},{"key":"10.1053\/srao.2001.26030_bib60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.genet.31.1.635","article-title":"Ataxia-telangiectasia and the Nijmegen breakage syndrome: Related disorders but genes apart","volume":"31","author":"Shiloh","year":"1997","journal-title":"Annu Rev Genet"},{"key":"10.1053\/srao.2001.26030_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)81547-0","article-title":"The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder","volume":"99","author":"Stewart","year":"1999","journal-title":"Cell"},{"key":"10.1053\/srao.2001.26030_bib62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.286.5442.1162","article-title":"Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks","volume":"286","author":"Cortez","year":"1999","journal-title":"Science"},{"key":"10.1053\/srao.2001.26030_bib63","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1053\/srao.2001.26030_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/35004614","article-title":"hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response","volume":"404","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1053\/srao.2001.26030_bib65","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1101\/gad.851000","article-title":"Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress","volume":"14","author":"Tibbetts","year":"2000","journal-title":"Genes Dev"},{"key":"10.1053\/srao.2001.26030_bib66","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0168-9525(98)01511-X","article-title":"Splitting the ATM: Distinct repair and checkpoint defects in ataxia-telangiectasia","volume":"14","author":"Jeggo","year":"1998","journal-title":"Trends Genet"},{"key":"10.1053\/srao.2001.26030_bib67","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/carcin\/17.11.2285","article-title":"Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells","volume":"17","author":"Boulton","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1053\/srao.2001.26030_bib68","first-page":"246","article-title":"The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage","volume":"56","author":"Price","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib69","first-page":"1149","article-title":"Radiosensitization of human tumor cells by the phospatidylinositol 3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay","volume":"3","author":"Rosenzweig","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib70","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0092-8674(95)90482-4","article-title":"DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product","volume":"82","author":"Hartley","year":"1995","journal-title":"Cell"},{"key":"10.1053\/srao.2001.26030_bib71","first-page":"4375","article-title":"Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin","volume":"58","author":"Sarkaria","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2307\/3579783","article-title":"Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells","volume":"149","author":"Okayasu","year":"1998","journal-title":"Radiat Res"},{"key":"10.1053\/srao.2001.26030_bib73","first-page":"4375","article-title":"Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine","volume":"59","author":"Sarkaria","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib74","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0960-9822(99)80486-2","article-title":"Caffeine inhibits the checkpoint kinase ATM","volume":"9","author":"Blasina","year":"1999","journal-title":"Curr Biol"},{"key":"10.1053\/srao.2001.26030_bib75","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1074\/jbc.275.14.10342","article-title":"Caffeine abolishes the mammalian G(2)\/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity","volume":"275","author":"Zhou","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/srao.2001.26030_bib76","first-page":"1643","article-title":"Differential sensitivity of p53(\u2212) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay","volume":"55","author":"Powell","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib77","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nm1096-1140","article-title":"Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase","volume":"2","author":"Yao","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/srao.2001.26030_bib78","first-page":"1639","article-title":"Abrogation of the G2 checkpoint-deficient and G1 checkpoint-competent cells","volume":"55","author":"Russell","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib79","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0360-3016(96)00432-4","article-title":"Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines","volume":"36","author":"Russell","year":"1996","journal-title":"Inter J Radiat Oncol, Bio, Phys"},{"key":"10.1053\/srao.2001.26030_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3835(99)00449-8","article-title":"Caffeine enhanced radiosensitivity of rat tumor cells with a mutant-type p53 by inducing apoptosis in a p53-independent manner","volume":"152","author":"Higuchi","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1053\/srao.2001.26030_bib81","first-page":"1371","article-title":"Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and\/or the induction of giant cells in colorectal tumor cells with disrupted p53 function","volume":"3","author":"Bracy","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/srao.2001.26030_bib82","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2","article-title":"A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma","volume":"68","author":"Kelsen","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/srao.2001.26030_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00000421-200008000-00022","article-title":"Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: A phase II study","volume":"23","author":"Ahmed","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/srao.2001.26030_bib84","first-page":"2137","article-title":"Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma","volume":"20","author":"Tsuchiya","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1053\/srao.2001.26030_bib85","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00003086-199901000-00005","article-title":"Marginal excision for ostcosarcoma with caffeine assisted chemotherapy","volume":"358","author":"Tsuchiya","year":"1999","journal-title":"Clin Orthop"},{"key":"10.1053\/srao.2001.26030_bib86","first-page":"801","article-title":"A phase II evaluation of pentoxifylline combined with radiation in the treatment of brain metastase","volume":"13","author":"Johnson","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1053\/srao.2001.26030_bib87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1005788121043","article-title":"Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas","volume":"32","author":"Stewart","year":"1997","journal-title":"J Neurooncol"},{"key":"10.1053\/srao.2001.26030_bib88","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0360-3016(92)90846-A","article-title":"Increases in tumor response by pentoxifylline alone or in combination with nicotinamide","volume":"22","author":"Lee","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/srao.2001.26030_bib89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09553009314551351","article-title":"Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline","volume":"64","author":"Lee","year":"1993","journal-title":"Int J Radiat Biol"},{"key":"10.1053\/srao.2001.26030_bib90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2307\/3578277","article-title":"Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline","volume":"130","author":"Song","year":"1992","journal-title":"Radiat Res."},{"key":"10.1053\/srao.2001.26030_bib91","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-8140(00)00221-8","article-title":"Effect of pentoxifylline on radiation response of non-small cell lung cancer: A phase III radomized multicenter trial","volume":"56","author":"Kwon","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1053\/srao.2001.26030_bib92","doi-asserted-by":"crossref","first-page":"L776","DOI":"10.1152\/ajplung.1999.276.5.L776","article-title":"Effects of lisofylline on hyperoxia-induced lung injury","volume":"20","author":"George","year":"1999","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1053\/srao.2001.26030_bib93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1702114","article-title":"A randomized placebocontrolled trial of lisofylline in HLA-identical, siblingdonor, allogeneic bone marrow transplant recipients","volume":"25","author":"List","year":"2000","journal-title":"The Lisofylline Marrow Transplant Study Group. Bone Marrow Transplant"},{"key":"10.1053\/srao.2001.26030_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.1998.4972","article-title":"Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum","volume":"70","author":"Husain","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1053\/srao.2001.26030_bib95","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jnci\/88.14.956","article-title":"UCN-01: A potent abrogator of G2 checkpoint function in cancer cells with disrupted p53","volume":"88","author":"Wang","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/srao.2001.26030_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1006313611677","article-title":"UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines","volume":"18","author":"Monks","year":"2000","journal-title":"Invest New Drugs"},{"key":"10.1053\/srao.2001.26030_bib97","first-page":"A612","article-title":"Phase I trial of infusional UCN-01, a novel protein kinase inhibitor, in patients with refractory neoplasms","volume":"18","author":"Senderowicz","year":"1999"},{"key":"10.1053\/srao.2001.26030_bib98","first-page":"A611","article-title":"Phase I study of UCN-01 by 3-hour infusion","volume":"18","author":"Tamura","year":"1999"},{"key":"10.1053\/srao.2001.26030_bib99","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1074\/jbc.275.8.5600","article-title":"The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01","volume":"275","author":"Graves","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/srao.2001.26030_bib100","first-page":"2108","article-title":"The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1","volume":"60","author":"Busby","year":"2000","journal-title":"Cancer Res"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429601800680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429601800680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:46:07Z","timestamp":1682138767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429601800680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S1053429601800680"],"URL":"https:\/\/doi.org\/10.1053\/srao.2001.26030","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}